Reply to "Financial hindrances to introducing higher-valent pediatric combination vaccines".
作者信息
Huang Aodi, Xu Xia, Tang Lin, Wang Fuzhen
机构信息
National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing, China.
出版信息
Hum Vaccin Immunother. 2024 Dec 31;20(1):2364509. doi: 10.1080/21645515.2024.2364509. Epub 2024 Jul 8.
Abstract
摘要
相似文献
1
Reply to "Financial hindrances to introducing higher-valent pediatric combination vaccines".对《引入更高价儿科联合疫苗的财务障碍》的回复
Hum Vaccin Immunother. 2024 Dec 31;20(1):2364509. doi: 10.1080/21645515.2024.2364509. Epub 2024 Jul 8.
2
Financial hindrances to introducing higher-valent pediatric combination vaccines.引入更高价儿科联合疫苗的经济障碍。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2364497. doi: 10.1080/21645515.2024.2364497. Epub 2024 Jul 8.
3
Financial barriers to the adoption of combination vaccines by pediatricians.儿科医生采用联合疫苗的经济障碍。
Arch Pediatr Adolesc Med. 2010 Dec;164(12):1138-44. doi: 10.1001/archpediatrics.2010.222.
4
Parental and societal values for the risks and benefits of childhood combination vaccines.儿童联合疫苗的风险和收益的父母和社会价值观。
Vaccine. 2012 May 14;30(23):3445-52. doi: 10.1016/j.vaccine.2012.03.022. Epub 2012 Mar 23.
5
Rejoinder to comments on ''Acceptance and willingness to pay for DTaP-HBV-IPV-Hib hexavalent vaccine among parents: A cross-sectional survey in China''.对《家长对吸附无细胞百白破-乙型肝炎-灭活脊髓灰质炎- b型流感嗜血杆菌联合疫苗的接受度及支付意愿：中国的一项横断面调查》评论的回应
Hum Vaccin Immunother. 2024 Dec 31;20(1):2375668. doi: 10.1080/21645515.2024.2375668. Epub 2024 Jul 18.
6
New vaccines against otitis media: projected benefits and cost-effectiveness.预防中耳炎的新型疫苗：预期效益与成本效益分析
Pediatrics. 2009 Jun;123(6):1452-63. doi: 10.1542/peds.2008-1482.
7
The hidden costs of infant vaccination.婴儿疫苗接种的隐性成本。
Vaccine. 2000 Aug 15;19(1):33-41. doi: 10.1016/s0264-410x(00)00154-7.
8
[Combined vaccines: a useful opportunity in public health].[联合疫苗：公共卫生领域的一个有益契机]
Ann Ig. 2002 Jul-Aug;14(4 Suppl 4):69-75.
9
[A new combined vaccine. 6 at once].[一种新型联合疫苗。一次接种6种]
MMW Fortschr Med. 2000 Jul 20;142(28-29):57.
10
Budget impact analysis of introducing a non-reconstituted, hexavalent vaccine for pediatric immunization in the United Kingdom.在英国引入一种非重组、六价疫苗进行儿童免疫接种的预算影响分析。
Expert Rev Vaccines. 2020 Dec;19(12):1167-1175. doi: 10.1080/14760584.2020.1873770. Epub 2021 Jan 27.
引用本文的文献
1
Rejoinder to comments on ''Acceptance and willingness to pay for DTaP-HBV-IPV-Hib hexavalent vaccine among parents: A cross-sectional survey in China''.对《家长对吸附无细胞百白破-乙型肝炎-灭活脊髓灰质炎- b型流感嗜血杆菌联合疫苗的接受度及支付意愿：中国的一项横断面调查》评论的回应
Hum Vaccin Immunother. 2024 Dec 31;20(1):2375668. doi: 10.1080/21645515.2024.2375668. Epub 2024 Jul 18.
本文引用的文献
1
The landscape of vaccines in China: history, classification, supply, and price.中国疫苗的概况：历史、分类、供应和价格。
BMC Infect Dis. 2018 Oct 4;18(1):502. doi: 10.1186/s12879-018-3422-0.
Zotero 插件